EXTON, Pa., Sept. 29 /PRNewswire-FirstCall/ -- Kensey Nash Corporation is scheduled to present at the JMP Securities Fourth Annual Healthcare Focus Conference at The New York Palace in New York City on Tuesday, October 6, 2009.
Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation, beginning at approximately 2:30 p.m. (ET). To hear the live webcast of the Kensey Nash presentation at the JMP Securities Fourth Annual Healthcare Focus Conference, go to http://www.wsw.com/webcast/jmp9/knsy/ and access the conference link. The presentation materials will also be available on the company's website (http://www.kenseynash.com/) beginning at 2:30 p.m. (ET) on Tuesday, October 6, 2009.
About Kensey Nash Corporation. Kensey Nash Corporation is a leader in developing, manufacturing and processing resorbable biomaterial products, incorporating its proprietary collagen and synthetic polymer technology. This expertise is used to develop and commercialize its products through strategic partners. The company has an extensive range of products, which are sold in multiple medical markets, including, the cardiology, orthopedic, sports medicine, spine, endovascular and general surgery markets. The company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal Vascular Closure Device, which is licensed to St. Jude Medical, Inc.
Kensey Nash Corporation
CONTACT: Joseph W. Kaufmann, President and Chief Executive Officer of
Kensey Nash Corporation, +1-484-713-2100
Web Site: http://www.kenseynash.com/
